The BrainChip Holdings Ltd (ASX: BRN) share price is in focus after the company reported a 19% lift in half-year revenue to US$1.22 million, with a net loss after tax of US$12.0 million as it accelerates on commercialising its neuromorphic AI technology.
What did BrainChip report?
- Revenue of US$1,222,745, up 19% from 1H 2025
- Net loss after tax of US$12,015,897 (1H 2025: US$9,360,251)
- Operating expenses increased 33% to US$13,647,140
- Cash and cash equivalents of US$20,304,971 as at 30 June 2026
- No interim dividend declared
What else do investors need to know?
BrainChip achieved a significant operational milestone by shipping the first production batch of 2,000 AKD1500 neuromorphic processors, marking the transition from pre-production to commercial-scale manufacturing. The company is also developing AKD1500-based hardware platforms to support faster customer adoption.
During the half, BrainChip signed new intellectual property (IP) licensing deals with EDGEAI and ASICLAND, opening up new streams for potential licensing and royalty revenue. The ecosystem expanded through a new partnership with MicroIP, while dedicated product platforms for defence, industrial AI, and signal analytics were advanced.
Costs rose as BrainChip invested in R&D, commercialisation efforts, and supporting its next-generation AKD2500 chipâstill tracking for a late-2026 development milestone. The company’s financing facility with LDA Capital concluded during the period, with all obligations substantially settled.
What’s next for BrainChip?
BrainChip is focused on broadening commercial deployment of its Akida neuromorphic technology across defence, industrial, and edge AI markets. The company expects further product shipments, ecosystem partnerships, and customer integrations in the coming months.
Development of the AKD2500 chip and BrainChip’s Generative AI program remain key priorities, with internal demonstrations of its GenAI platform targeted by year-end. Management says groundwork is being laid for increased commercial and licensing revenue ahead of anticipated larger-scale customer uptake.
BrainChip share price snapshot
Over the past 12 months, BrainChip shares have declined 33%, trailing the All Ordinaries Index (ASX: XAO), which has risen 1% over the same period.
The post BrainChip shares: Half-year results show revenue up, loss widens appeared first on The Motley Fool Australia.
Should you invest $1,000 in BrainChip right now?
Before you buy BrainChip shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and BrainChip wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 1 August 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.